IQVIA MedTech NV
0873.863.003 · rovalta.com · 25/09/2026
IQVIA MedTech NV
Financial year 2023 · Closed on 31/12/2023
Overview
Identity
Source · BCE/KBOIQVIA MedTech NV is a Public limited company incorporated in 2005. Its main activity is: Technical testing and analysis. Its registered office is in Antwerpen. It employs on average 31,6 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0873.863.003
- Incorporation
- 18/05/2005
- Legal form
- Public limited company
- Registered office
- Berchemstadionstraat 78
2600 Antwerpen · FlandreSee on map - Contributed capital
- 0,00 €
- Latest accounts
- 31/12/2023
- Average workforce
- 31,6 ETP
Joint committees (3)
- 100
- 200
- 218
Financials
Source · NBB, 20 filingsTrend over 14 financial years
| 2023 | 2022 | 2021 | 2017 | 2016 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 5,6 M € | -64.0% | 15,6 M € | +19.2% | 13,1 M € | +145% | 5,4 M € | +16.3% | 4,6 M € |
| EBITDA | -5,4 M € | -567% | 1,2 M € | -43.4% | 2 M € | +272% | 547,7 k € | +9.6% | 499,9 k € |
| Operating result | -5,4 M € | -1175% | 504,6 k € | -46.5% | 943,4 k € | +153% | 372,9 k € | +32.7% | 281,1 k € |
| Net result | -3,5 M € | -715% | 575,8 k € | -83.6% | 3,5 M € | +1461% | 224,5 k € | +260% | -140,3 k € |
| Balance sheet | |||||||||
| Equity | 34,2 M € | +205% | 11,2 M € | +5.4% | 10,6 M € | +241% | 3,1 M € | +7.8% | 2,9 M € |
| Total assets | 52,2 M € | +118% | 24 M € | +11.7% | 21,5 M € | +293% | 5,5 M € | +19.8% | 4,6 M € |
| Cash | 5 M € | +26.8% | 4 M € | +101% | 2 M € | +544% | 306,6 k € | -60.4% | 774,1 k € |
| Debts | 17,6 M € | +39.6% | 12,6 M € | +21.9% | 10,3 M € | +377% | 2,2 M € | +35.6% | 1,6 M € |
| Other | |||||||||
| Workforce | 31,6 ETP | 0.0% | 31,6 ETP | -16.4% | 37,8 ETP | +168% | 14,1 ETP | +16.5% | 12,1 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20233 active · 31 ended
Active mandates
Ended mandates
Other companies at this address
Berchemstadionstraat 78 2600 Antwerpen| Company | CBE no. |
|---|---|
Aurum Strength Private Gym● Active | 0780.480.608 |
buro Medical Uitzend● Active | 0765.334.552 |
BURO NEXUS● Active | 0628.499.622 |
CWS Cleanrooms België● Active | 0436.226.222 |
CWS HYGIENE BELGIE● Active | 0423.205.456 |
CWS WORKWEAR BELGIE● Active | 0403.828.420 |
SwS Partners● Active | 1013.013.263 |
TENNANT EUROPE● Active | 0477.652.843 |
TVM Belgium Insurance● Active | 0778.969.881 |
TVM brokerage● Active | 0429.507.486 |
TVM Letselschaderegeling België● Active | 0442.772.930 |
TVM solutions● Active | 0472.210.351 |
Financials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 |
| Closing of the financial year | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/12/2024 | 14/03/2025 | 28/07/2022 | 05/07/2021 | 30/07/2020 | 25/07/2019 |
| General meeting | 20/12/2024 | 28/02/2025 | 26/07/2022 | 11/06/2021 | 29/07/2020 | 22/07/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2023 | 20/12/2024 | 23/12/2024 | Dutch | |
| Full modelCorrection | 31/12/2022 | 28/02/2025 | 14/03/2025 | Dutch | |
| Full model | 31/12/2022 | 29/11/2024 | 29/11/2024 | Dutch | |
| Full model | 31/12/2021 | 26/07/2022 | 28/07/2022 | Dutch | |
| Full model | 31/12/2020 | 11/06/2021 | 05/07/2021 | Dutch | |
| Full model | 31/12/2019 | 29/07/2020 | 30/07/2020 | Dutch | |
| Full model | 31/12/2018 | 22/07/2019 | 25/07/2019 | Dutch | |
| Consolidated accounts | 31/12/2018 | 01/01/9999 | 25/07/2019 | Dutch | |
| Full model | 31/12/2017 | 08/06/2018 | 06/07/2018 | Dutch | |
| Consolidated accounts | 31/12/2017 | 01/01/9999 | 29/06/2018 | Dutch | |
| Full model | 31/12/2016 | 09/06/2017 | 19/06/2017 | Dutch | |
| Full model | 31/12/2015 | 30/06/2016 | 20/07/2016 | Dutch | |
| Full model | 31/12/2014 | 12/06/2015 | 17/07/2015 | Dutch | |
| Abridged model | 30/06/2013 | 07/12/2013 | 16/01/2014 | Dutch | |
| Abridged model | 30/06/2012 | 01/12/2012 | 03/01/2013 | Dutch | |
| Abridged model | 30/06/2011 | 03/12/2011 | 14/12/2011 | Dutch | |
| Abridged model | 30/06/2010 | 04/12/2010 | 22/12/2010 | Dutch | |
| Abridged model | 30/06/2009 | 05/12/2009 | 14/12/2009 | Dutch | |
| Abridged model | 30/06/2008 | 06/12/2008 | 15/12/2008 | Dutch | |
| Abridged model | 30/06/2007 | 01/12/2007 | 19/12/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 25 M€ and 50 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20233 active · 31 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates03/08/2023MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
- Mandates01/03/2023ONTSLAGEN - BENOEMINGEN
- Mandates05/09/2022ONTSLAGEN - BENOEMINGEN
- Mandates17/08/2022ONTSLAGEN - BENOEMINGEN
- Mandates04/07/2022ONTSLAGEN - BENOEMINGEN
- Mandates17/03/2021ONTSLAGEN - BENOEMINGEN
- Mandates15/01/2021ONTSLAGEN - BENOEMINGEN
- Other14/01/2021BENAMING
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 2023-3,5 M €↓
- 06/07/2023nominationEmmanuel Vanderhaegen — gedelegeerd bestuurder
- 06/07/2023nominationClément Vanthournhout — bestuurder
- 06/07/2023nominationPatrick Van Dooren — bestuurder
- 01/02/2023nominationEmmanuel Vanderhaegen — bestuurder
- 2022Annual accounts 2022575,8 k €↓
- 26/07/2022nominationMazars Bedrijfsrevisoren CV — commissaris
- 26/07/2022nominationPeter Lenoir — permanent vertegenwoordiger
- 01/06/2022nominationBrad Thomas — bestuurder
- 2021Annual accounts 20213,5 M €↑
- 2021Name changeIQVIA MedTech
- 2017Annual accounts 2017224,5 k €↑
- 2016Annual accounts 2016-140,3 k €↓
- 2015Annual accounts 2015133,6 k €↓
- 2014Annual accounts 2014155,4 k €↓
- 2013Annual accounts 2013490,6 k €↑
- 2012Annual accounts 2012487,7 k €↓
- 2011Annual accounts 2011756,3 k €↑
- 2010Annual accounts 2010226,5 k €↑
- 2009Annual accounts 200938,9 k €↓
- 2008Annual accounts 200861 k €↓
- 2007Annual accounts 2007184,9 k €
- 2007Name changeGENAE ASSOCIATES
- 18/05/2005IncorporationPublic limited company